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Dans ce texte, les auteures relient la 
vaccination hpv ( papillomavirus hu-
main) à un processus socio-politique 
élargi qui veut médicaliser et pa-
thologiser la sexualité féminine. Deux 
jeunes femmes qui ont refusé le vaccin 
nous racontent la lutte et les tensions 
qu’elles ont vécues quand elles ont af-
firmé leur position contre la vaccina-
tion.
In July 2006, Health Canada ap-
proved a vaccine called GardasilTM 
for use in girls and young women 
aged 9 to 26. The vaccine aims to 
prevent against four strains of hu-
man papillomavirus (hpv), two of 
which have been associated with the 
development of genital warts, and 
two of which have been associated 
with the development of cervical 
cancer (Centers for Disease Con-
trol). Following the vaccine’s ap-
proval by Health Canada, and with 
the assistance of federal funding, the 
Ontario government launched a vol-
untary school-based vaccination in 
program in 2007 for girls in grade 
eight (Torgerson and MacAdam). 
Currently, publicly funded hpv vac-
cination programs are available in 
all provinces and territories (Public 
Health Agency of Canada). Those 
who are not eligible for vaccination 
through school-based programs must 
purchase the vaccine at a cost of ap-
proximately $400- $450 if they wish 
to be vaccinated (Comeau 913).
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Whereas the rationale for mass 
immunization during grade school 
derives from the recommendation 
to vaccinate before sexual onset, uni-
versity-aged women, many of whom 
are already sexually active, have been 
heavily targeted by government and 
industry-sponsored media advertise-
ments about hpvand Gardasil. The 
language and images used both in in-
dustry-sponsored advertisements and 
health information materials for hpv 
vaccination exhort young women to 
assume responsibility for their sexual 
health and to protect themselves from 
cervical cancer by “choosing” to vacci-
nate. While floor-to-ceiling print ads 
conspicuously wallpaper university 
corridors and call on young women 
to be “smart” ” and “do all they can” 
to avoid getting cancer, television ad-
vertisements and pamphlets littered 
across university campuses, in sexual 
health clinics, and in doctors’ offices, 
instruct young women to “spread the 
word” and “not the disease” (Polzer 
and Knabe 869). Such messages not 
only blur the line between public 
health education and the marketing 
of pharmaceutical products, but they 
also reinforce assumptions about the 
female body as a primary vector of 
sexually-transmitted infections and 
site of risk for future disease (cervical 
cancer). The pervasiveness of such 
messages sets up a moral landscape 
in which saying “no” to vaccination 
is interpreted, at best, as a sign of 
ignorance, and, at worst, as a sign of 
negligence to care for one’s own health 
and the health of others (Polzer and 
Knabe 869).
 
Decision-Making, Risk and 
Neo-medicalization
To date, most studies on hpv deci-
sion-making have been quantitative 
in design and have thus relied on 
structured questionnaires or surveys 
that provide participants with a list 
of pre-determined options regarding 
what factors influence their deci-
sion-making. Furthermore, research 
on decision-making in the field of 
health education tends to assume an 
overly simplistic view of how people 
make decisions in the context of 
their everyday lives. Often, decision-
making is framed as a linear process 
which involves individuals weighing 
the pros and cons to arrive at a final 
“rational” decision at a specific point 
in time. Indeed, in the context of 
hpv vaccination, decisions to vac-
cinate are framed as the smart and 
rational choice for young women. 
As a result, it is often assumed (and 
expected) that once women are pro-
vided with information about hpv 
and its link to cervical cancer, they 
will readily accept vaccination as the 
appropriate preventative action. 
The concept of neomedicalization 
is useful to situate young women’s 
decision making about hpv vaccina-
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tion within the broader socio-political 
matrix. Batt and Lippman define 
“neomedicalization” as a form of 
medicalization which “emphasizes an 
individual’s supposed risk of develop-
ing a problem and the use of some 
drug or device to manage this risk. In 
its most expansive form, neomedical-
ization makes being ‘at-risk’ a disease 
state and frames the individual as 
responsible for ensuring that the risk 
responsibility and personal control 
over health, neoliberal discourses 
on health risk conveniently co-opt 
feminist challenges to medicalization 
that emphasize autonomy and taking 
charge of one’s heath. 
Furthermore, individuals are in-
creasingly framed by risk discourse 
as having a responsibility to preserve 
their health not only for their own 
benefit, but for the benefit of fam-
undertaken. As a unique approach 
to qualitative health research, narra-
tive methodology was used as a way 
to gain insight into young women’s 
personal experiences for two rea-
sons. First, the use of a narrative 
methodological approach provided 
participants the opportunity to de-
fine their experiences in their own 
ways rather than have their realities 
be shaped by structured data col-
does not become reality” (50). As Batt 
and Lippman point out, processes of 
neomedicalization are symptomatic 
of neo-liberal policies which construct 
health as a malleable commodity and 
basis for economic growth through 
the expansion of drug interventions 
aimed at managing risks to health (50-
51) and place responsibility for risk 
management squarely on the shoul-
ders of individuals and families who 
are expected to consume these drugs 
and devices. Processes of neomedi-
calization thus serve to individualize 
risks to health and to deflect attention 
from structural issues that determine 
health. In the context of hpv, these 
broader considerations include access 
to cervical cancer screening and the 
broader social determinants of health 
which render marginalized women 
(e.g. recent immigrants, Aboriginal 
women, women on low-income) 
particularly vulnerable to hpv and 
cervical cancer. 
By linking sexual activity with risks 
for acquiring hpv and hpv with the 
possibility of developing cervical 
cancer in the future, discourses on 
hpv vaccination represent a contem-
porary expression and extension of the 
pathologization of female sexuality 
and construct young women as appro-
priate targets for neomedicalization. 
With emphasis placed on individual 
ily members, and society as a whole 
(Peterson and Lupton 82). According 
to Petersen and Lupton, discourses of 
citizenship and personal responsibil-
ity are embodied in a particular way 
by women as neo-liberal subjects. As 
they describe, “the meanings associ-
ated with ‘health’ and ‘protective be-
haviours’ are inextricably linked with 
the feminised discourses of ‘looking 
after yourself ’, risk avoidance and 
caution, and are highly embodied” 
(82). This has implications for young 
women who may feel compelled to 
perform their independence and 
exercise their responsibility to do 
the “right thing” by managing their 
risks for future cancer through vac-
cination. In the context of dominant 
discourses on health risk, and the 
media advertisements for hpv vac-
cination, as outlined above, some 
young women may find it difficult 
to adopt a critical perspective on the 
vaccine and to justify their decisions 
to postpone or decline vaccination 
altogether. 
The Study
In order to learn more about how 
young women make decisions about 
hpv vaccination, a narrative study 
of young women’s decision-mak-
ing concerning hpv vaccination was 
lection methods. Second, narrative 
allows us to learn about the ways 
in which narrators, through their 
personal stories, reproduce larger 
discourses and struggle with ten-
sions in articulating their stories as 
they make sense of their experiences 
(Chase 651). Such tensions often 
point to the ways in which partici-
pants are challenging or resisting 
dominant discourses (Mishler 87).
In-depth interviews were conduct-
ed with five young women between 
the ages of 18 and 26, each of whom 
participated in two interviews. In the 
first interview, participants were asked 
to respond to the question: “In as 
much detail as possible, tell me your 
story of how you came to be/not be 
vaccinated against hpv.” The second 
interview was used as an opportunity 
to seek further detail on stories that 
were introduced in Interview 1. The 
analysis was conducted iteratively 
and in two general phases. During 
the first phase, narratives for each 
participant were constructed through 
the processes of “narrative creating” 
and “narrative finding” (Kvale 199). 
“Narrative finding” refers to looking 
for portions in the interviews that are 
essentially intact stories whereas “nar-
rative creating” refers to weaving the 
un-storied aspects of the interviews 
into each participant’s narrative 
By linking sexual activity with risks for acquiring hpv, and hpv 
with the possibility of developing cervical cancer in the future, 
discourses on hpv vaccination represent a contemporary expression 
and extension of the pathologization of female sexuality.
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(Kvale 199). During the second phase 
of analysis, the individual narratives 
were reviewed in order to develop 
cross-narrative themes. 
Although attempts were made 
to obtain a diverse sample, all five 
study participants were students at 
the university where the study was 
conducted. Although this imposed 
limitations with regard to the demo-
graphic diversity of the study partici-
pants, the sample was diverse in terms 
of the decisions participants reached 
in relation to hpv vaccination: two 
of the women had accepted and had 
already been vaccinated, two of the 
women had declined vaccination, 
and one participant was undecided 
about vaccination at the time of 
recruitment. 
In what follows, we focus on the 
individual narratives of the two study 
participants who declined vaccina-
tion, Ana and Kristin (pseudonyms), 
in order to illustrate the struggles and 
tensions that these young women 
experienced as they attempted to 
adopt critical positions in relation 
the vaccine. In contrast to the nar-
ratives of those participants who had 
been vaccinated, both of these young 
women’s narratives were fraught with 
difficulties as they described and 
defended their decisions not to be 
vaccinated. In presenting these narra-
tives, we raise questions and provoke 
critical reflection about what such 
cancer prevention discourses mean for 
young women’s autonomy in health 
decision making. 
Ana’s Narrative
Ana’s narrative was shaped by her 
strong personal ethic when it comes 
to taking medications and vaccines. 
Throughout both interviews, Ana 
described her strong personal ethic 
against putting “foreign” things into 
her body unless she knows “what’s 
gonna happen afterwards.” In dis-
cussing the hpv vaccine, Ana said 
she is “wary” of the possible long-
term side effects of vaccination be-
cause there is too much “unknown.” 
Ana used the example of the “drug 
that gave babies no arms” (Thalido-
mide) to show how an approved 
drug still turned out to be unsafe. 
Ultimately, Ana said that unless she 
is “100 percent sure” that the vac-
cine is something that will protect 
her health, she will just continue to 
“go for the cautious end of it and 
just not do it.”
Of particular interest in Ana’s nar-
rative, is her struggle to align who 
she is with how she came to decline 
vaccination. For Ana, this struggle re-
sults in two competing ways of seeing 
herself. On the one hand she describes 
herself as “critical”, “educated”, and 
“cautious,” while on the other hand, 
she describes herself as “lazy” and “pas-
sive.” According to Ana, her ability 
to be critical and cautious “comes 
from six years of being in university” 
during which, in “almost every class”, 
she was told that “it’s all about critical 
thinking.” Ana described her critical 
way of thinking as a “revelation” that 
came from her being a student in a 
“feminist based program” that has 
taught her a lot about “social issues 
and social justice.” 
Despite expressing confidence in 
her critical perspective, Ana simul-
taneously described herself as “lazy” 
and “passive.” In this sense, Ana 
felt that her critique of the vaccine 
did not have a strong foundation 
since she had “never done any more 
research” or “sought out any oppos-
ing information”. The fact that she 
hadn’t sought out information about 
the vaccine led her to describe herself 
not just as “sceptical” but also as 
“ignorant.” Ana described her failure 
to put in the “extra effort” and seek 
information as part of her usual 
“lazy way.” In the second interview, 
Ana began to question her decision 
against vaccination and suggested 
that maybe it was “stupidity” on her 
part because she “should” be taking 
care of her body. By the end of the 
second interview, Ana acknowledged 
the tension between her two compet-
ing selves by outlining two distinct 
types of people. As she described, 
“you could be the really proactive 
type and really do that research and 
really be educated and you know, be 
a good person or you could be the 
person who just takes information as 
it’s provided to them.” For Ana, this 
distinction was an important one in 
that she described herself as someone 
in the “middle of the road.” 
Kristin’s Narrative
Kristin began her narrative by list-
ing the main reasons why she is “not 
really for” the vaccine. Within the 
first few minutes of her interview, 
Kristin had already listed at least 
four reasons why she chose not to 
be vaccinated. In addition to not 
seeing “the need for it” and viewing 
it as “just another tool” in addition 
to pap smears, she also questioned 
“how effective the vaccine would 
be” since she has had “multiple 
sexual partners” and therefore has 
already likely “been exposed” to the 
virus. 
Once she finished listing her rea-
sons for not wanting to be vaccinated, 
Kristin went on to describe how she 
has had to defend her decision not 
to be vaccinated on a number of 
occasions with her friends, and how 
she has been labelled as “irrational” 
and “stubborn” by her boyfriend and 
others when she raises her concerns 
about the potential side effects of the 
vaccine. As Kristin described, one 
friend (who had gotten the vaccine) 
was “aghast” at her decision and asked 
why she wasn’t getting the vaccine 
as well. Kristin responded by saying 
that she is “wary of pharmaceutical 
companies and wonder drugs” and 
that she is “not scared to wait five years 
just to see how it all pans out.” Kristin 
also noted that her male friends have 
also offered their opinions by saying 
“it’s your body, it’s your decision, 
but why wouldn’t you wanna’ fight 
a cancer that you could?” According 
to Kristin, being “perceived” as “ir-
rational or emotional” in her “decision 
making” is a “pet peeve” of hers. As she 
described, “it’s a nerve that’s picked 
with me because I know I’m very 
rational in all of my choices.” 
Kristin also emphasized her con-
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cern with her reproductive future in 
her narrative. In order to articulate 
her concerns regarding the safety of 
the vaccine, Kristin, like Ana, drew 
on the example of “Thalidomide” 
which she says “really resonates” 
with her. For Kristin, the hpv vac-
cine, like Thalidomide, may turn 
out to be “not-so-great” if it causes 
“more problems having children, or 
if there are side effects, difficulties, 
sand” when she tells them to “go get 
pap smears.”
According to Kristin, being “well 
versed” in sexual health matters is a 
“responsibility” that “comes along 
with the privilege of being sexu-
ally active.” As she described, “I’ve 
always thought that sexual health is 
my responsibility and that I should 
know what’s out there, know the 
consequences and the repercussions 
she should do all she can, including 
vaccination, in order to reduce her 
risks for cervical cancer. 
Indeed, the power of risk discourse 
in influencing Ana’s view of herself is 
evidenced in how she feels compelled 
to question and judge herself for not 
seeking out information and becom-
ing more informed about the vaccine. 
The discourse of morality which per-
meates notions of risk management 
or problems with pregnancies” in 
the long term. She emphasized that, 
since no information is currently 
available regarding the potential side 
effects of the vaccine, she has decided 
that she is “willing to wait” to see if 
it has any effects on “fertility” in the 
long term.
According to Kristin, she took it 
upon herself to become “informed” 
about the hpv vaccine because she 
felt it was her “responsibility” to do 
so. Despite seeing “commercials” 
about the vaccine, reading many 
“news stories,” and visiting multiple 
“websites,” she noted that the vaccine 
never really “perked” her interest 
because she “didn’t see the need for 
it.” For Kristin, its “role” as she saw 
it, was already being filled in her 
“health portfolio.” As she described, 
“I think paps (Papanicolaou smears 
or tests) are sufficient because I’m on 
top of them and I do all my sexual 
health things.” 
Although Kristin described herself 
as responsible and aware of her “sexual 
health” options, she said she was “ir-
ritated” that her mom and sister were 
different from her in this way. As she 
described, they “won’t take ownership 
of their own reproductive health” and 
“they don’t do anything sexual health 
reproduction wise.” Instead, Kristin 
said they just “bury their heads in the 
so that I do actually know the full 
gamut or the weight of the decisions 
I’m making.”
Discussion
Ana and Kristin’s narratives demon-
strate that decisions regarding hpv 
vaccination result from processes 
that are complex and ongoing, and 
are inevitably located within, and 
influenced by, dominant discourses 
on health risk. Although Ana and 
Kristin were both critical of the hpv 
vaccine as a risk-reduction measure 
and concerned about its safety, the 
narratives of both of these young 
women show that they oriented 
their decisions in relation to domi-
nant discourses on health risk which 
promote individual responsibility 
for health.
Ana’s narrative highlights her 
struggle to define who she is in re-
lation to her vaccination decision. 
Specifically, Ana struggles to make 
her decision not to seek vaccination 
or information about vaccination 
commensurate with moral discourses 
related to taking responsibility for 
one’s own health. Ultimately, Ana’s 
orientation as someone who is critical 
and cautious and her decision not to 
be vaccinated are at odds with risk 
discourse which promote the idea that 
and personal responsibility for health 
ultimately informed Ana’s consider-
ation that one of the reasons she hasn’t 
sought information is because of her 
own “stupidity” since she “should” 
be taking care of her own body. Ul-
timately, although Ana is attempting 
to challenge the imperative to get 
vaccinated and question the ways in 
which hpv has come to be constructed 
as a risk, she struggles to do so in the 
face of prevailing discourses which 
frame the vaccine as the appropriate 
and responsible choice.
Like Ana, Kristin is also critical 
of the hpv vaccine and struggles 
to resist dominant discourses that 
position the vaccine as the ideal 
risk-reduction tool. Much of Kristin’s 
narrative focuses on her experiences 
defending her decision to others, 
including those in her immediate 
social network. Whereas Ana judges 
herself for not seeking out informa-
tion about vaccination, judgements 
from Kristin’s friends arise from their 
understandings of hpv as a risk and 
vaccination as a means of controlling 
this risk through medical interven-
tion. Because Kristin’s decision to 
decline vaccination is at odds with 
risk-related discourses and the moral 
imperative of taking action to reduce 
one’s risk for disease, she is thus 
called upon to defend her decision 
Kristin’s decision to decline vaccination is at odds with risk-related 
discourses and the moral imperative of taking action to reduce 
one’s risk for disease, [and] she is thus called upon to defend her 
decision in order to avoid being labelled “irresponsible.” 
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in order to avoid being labelled “ir-
responsible.” 
In order to construct herself as a 
responsible risk manager in light of 
her refusal of hpv vaccination, Kristin 
describes herself as someone who, 
through yearly pap tests, does every-
thing she can to remain “aware” of her 
body and “what’s going on with it.” 
To this end, and in distinction from 
Ana, Kristin describes how she took 
it upon herself to become informed 
about hpv since she felt it was her 
“responsibility” to do so. 
Conclusion
The narratives of these young wom-
en illustrate that decision-making 
about hpv vaccination is complex 
and influenced by the broader so-
cial and political contexts in which 
dominant discourses on health risk 
circulate and operate. In their nar-
ratives, both Ana and Kristin draw 
on ideas about personal responsibil-
ity for health in their descriptions of 
themselves as people who, despite 
their decisions not to be vaccinated, 
manage their risks for cervical can-
cer in other ways (e.g. through reg-
ular Pap screening). Ana struggles 
to reconcile her failure to seek out 
information about the vaccine and 
her decision not to be vaccinated 
with moral discourses of assuming 
personal responsibility for health 
through risk management. In con-
trast, Kristin struggles to defend her 
refusal of the vaccine within her im-
mediate social network, yet remains 
confident in her construction of 
herself as a responsible risk manager 
through taking up the imperative to 
become informed about the vaccine 
and reconciling her refusal of the 
vaccine with her desire to protect 
and take responsibility for her re-
productive health. 
By showing how young women 
struggle to resist dominant discourses 
related to health risk and personal 
responsibility for health, this research 
makes a significant contribution 
to understanding how processes of 
neo-medicalization have come to 
construct hpv as a risk to women’s 
health and vaccination against hpv 
as a solution to managing this risk. 
As demonstrated in the narratives 
of Ana and Kristin, young women 
are responding to an implicit moral 
obligation to take up vaccination 
in order to construct themselves as 
responsible managers of their risks for 
cervical cancer. These findings raise 
critical questions about what such 
cancer prevention discourses mean for 
young women’s autonomy in health 
decision making in the context of 
neomedicalization. 
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